Actively Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2025-09-08
700
Participants Needed
26
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide (CGRP) or its receptor: monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) or gepants (rimegepant, atogepant) during a 2-year period observation phase.
CONDITIONS
Official Title
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with migraine according to ICHD-III criteria
- Prescribed erenumab, galcanezumab, fremanezumab, eptinezumab, atogepant, or rimegepant according to prescriber and local reimbursement criteria
- Signed informed consent form
You will not qualify if you...
- Presence of headache types other than migraine
- Active severe psychiatric condition or cognitive impairment affecting ability to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 26 locations
1
University of Miami, Miller School of Medicine
Miami, Florida, United States, 33136
Actively Recruiting
2
FLENI
Buenos Aires, Argentina
Actively Recruiting
3
Pontificia Universidad Católica de Chile
Santiago, Chile
Actively Recruiting
4
Neuromedica
Medellín, Colombia
Actively Recruiting
5
Special Hospital for Orthopedics and Rehabilitation "Martin Horvat" Rovinj-Rovigno
Rovinj, Croatia
Actively Recruiting
6
Charité Universitätsmedizin Berlin
Berlin, Germany
Actively Recruiting
7
LMU University Hospital
München, Germany
Actively Recruiting
8
University of L'Aquila
L’Aquila, Italy
Actively Recruiting
9
University of Modena and Reggio Emilia
Modena, Italy
Actively Recruiting
10
National Neurological Institute C. Mondino Foundation
Pavia, Italy
Actively Recruiting
11
IRCCS San Raffaele
Roma, Italy
Actively Recruiting
12
Universiti Putra Malaysia
Serdang, Selangor, Malaysia
Actively Recruiting
13
Neuroclinic Norway
Lillestrøm, Norway
Actively Recruiting
14
Wrocław Medical University
Wroclaw, Poland
Actively Recruiting
15
Hospital Santa Maria Lisbon
Lisbon, Portugal
Actively Recruiting
16
Germans Trias i Pujol Hospital
Badalona, Barcelona, Spain
Actively Recruiting
17
Vall d'Hebron University Hospital
Barcelona, Barcelona, Spain, 08035
Actively Recruiting
18
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Actively Recruiting
19
Fundació Sanitària Mollet
Mollet del Vallès, Barcelona, Spain
Not Yet Recruiting
20
Hospital de Viladecans
Viladecans, Barcelona, Spain
Actively Recruiting
21
Hospital General Universitario de Albacete
Albacete, Spain
Actively Recruiting
22
Fundación Jiménez Díaz
Madrid, Spain
Actively Recruiting
23
Hospital Universitario Gregorio Marañón
Madrid, Spain
Actively Recruiting
24
La Paz University Hospital
Madrid, Spain
Actively Recruiting
25
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Spain
Actively Recruiting
26
Mersin University
Mersin, Turkey (Türkiye)
Actively Recruiting
Research Team
P
Patricia Pozo-Rosich, MD, PhD
CONTACT
E
Edoardo Caronna, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here